Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment

Cancer is one of the most devastating and ubiquitous human diseases. Conventional therapies like chemotherapy and radiotherapy are the most widely used cancer treatments. Despite the notable therapeutic improvements that these measures achieve, disappointing therapeutic outcome and cancer reoccurren...

Full description

Bibliographic Details
Main Authors: Chaojie Zhu, Zhiheng Ji, Junkai Ma, Zhijie Ding, Jie Shen, Qiwen Wang
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/7/940
id doaj-6c061ea568f641bea7954034a3971a81
record_format Article
spelling doaj-6c061ea568f641bea7954034a3971a812021-07-23T14:00:19ZengMDPI AGPharmaceutics1999-49232021-06-011394094010.3390/pharmaceutics13070940Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer TreatmentChaojie Zhu0Zhiheng Ji1Junkai Ma2Zhijie Ding3Jie Shen4Qiwen Wang5Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaChu Kochen Honors College of Zhejiang University, Hangzhou 310058, ChinaChu Kochen Honors College of Zhejiang University, Hangzhou 310058, ChinaCollege of Letters & Science, University of California, Berkeley, CA 94704, USADepartment of Pharmacy, School of Medicine, Zhejiang University City College, Hangzhou 310015, ChinaDepartment of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaCancer is one of the most devastating and ubiquitous human diseases. Conventional therapies like chemotherapy and radiotherapy are the most widely used cancer treatments. Despite the notable therapeutic improvements that these measures achieve, disappointing therapeutic outcome and cancer reoccurrence commonly following these therapies demonstrate the need for better alternatives. Among them, bacterial therapy has proven to be effective in its intrinsic cancer targeting ability and various therapeutic mechanisms that can be further bolstered by nanotechnology. In this review, we will discuss recent advances of nanotechnology-facilitated bacteria-based drug and gene delivery systems in cancer treatment. Therapeutic mechanisms of these hybrid nanoformulations are highlighted to provide an up-to-date understanding of this emerging field.https://www.mdpi.com/1999-4923/13/7/940bacterial therapynanotechnologydrug and genedelivery systemcombinational therapycancer treatment
collection DOAJ
language English
format Article
sources DOAJ
author Chaojie Zhu
Zhiheng Ji
Junkai Ma
Zhijie Ding
Jie Shen
Qiwen Wang
spellingShingle Chaojie Zhu
Zhiheng Ji
Junkai Ma
Zhijie Ding
Jie Shen
Qiwen Wang
Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment
Pharmaceutics
bacterial therapy
nanotechnology
drug and gene
delivery system
combinational therapy
cancer treatment
author_facet Chaojie Zhu
Zhiheng Ji
Junkai Ma
Zhijie Ding
Jie Shen
Qiwen Wang
author_sort Chaojie Zhu
title Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment
title_short Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment
title_full Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment
title_fullStr Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment
title_full_unstemmed Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment
title_sort recent advances of nanotechnology-facilitated bacteria-based drug and gene delivery systems for cancer treatment
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2021-06-01
description Cancer is one of the most devastating and ubiquitous human diseases. Conventional therapies like chemotherapy and radiotherapy are the most widely used cancer treatments. Despite the notable therapeutic improvements that these measures achieve, disappointing therapeutic outcome and cancer reoccurrence commonly following these therapies demonstrate the need for better alternatives. Among them, bacterial therapy has proven to be effective in its intrinsic cancer targeting ability and various therapeutic mechanisms that can be further bolstered by nanotechnology. In this review, we will discuss recent advances of nanotechnology-facilitated bacteria-based drug and gene delivery systems in cancer treatment. Therapeutic mechanisms of these hybrid nanoformulations are highlighted to provide an up-to-date understanding of this emerging field.
topic bacterial therapy
nanotechnology
drug and gene
delivery system
combinational therapy
cancer treatment
url https://www.mdpi.com/1999-4923/13/7/940
work_keys_str_mv AT chaojiezhu recentadvancesofnanotechnologyfacilitatedbacteriabaseddrugandgenedeliverysystemsforcancertreatment
AT zhihengji recentadvancesofnanotechnologyfacilitatedbacteriabaseddrugandgenedeliverysystemsforcancertreatment
AT junkaima recentadvancesofnanotechnologyfacilitatedbacteriabaseddrugandgenedeliverysystemsforcancertreatment
AT zhijieding recentadvancesofnanotechnologyfacilitatedbacteriabaseddrugandgenedeliverysystemsforcancertreatment
AT jieshen recentadvancesofnanotechnologyfacilitatedbacteriabaseddrugandgenedeliverysystemsforcancertreatment
AT qiwenwang recentadvancesofnanotechnologyfacilitatedbacteriabaseddrugandgenedeliverysystemsforcancertreatment
_version_ 1721286436475371520